Scott Bader
About Scott Bader
Scott Bader is the Associate Scientific Director of Chemical Process Development at Bristol Myers Squibb in Summit, New Jersey. He has extensive experience in organic chemistry and biochemistry, having worked at Celgene and Pfizer, and holds advanced degrees from The Ohio State University, Boston College, and the University of Michigan.
Current Title and Role
Scott Bader currently holds the title of Associate Scientific Director | Chemical Process Development at Bristol Myers Squibb. He has been in this role since January 2020 and is based in Summit, New Jersey, United States.
Professional Experience at Bristol Myers Squibb
Scott Bader joined Bristol Myers Squibb in January 2020. As the Associate Scientific Director | Chemical Process Development, he plays a significant role in overseeing and advancing chemical process development within the company.
Previous Experience at Celgene
Prior to his current role, Scott Bader worked at Celgene as a Principal Scientist. He served in this capacity from 2017 to 2020 in Summit, New Jersey. During his tenure, he contributed to various scientific initiatives and projects within the organization.
Experience at Pfizer
Scott Bader had an extensive career at Pfizer before joining Celgene. He held multiple roles over nine years, including Senior Principal Scientist from 2015 to 2017, Principal Scientist from 2010 to 2015, and Process Chemist from 2008 to 2010. His work was primarily based in Groton, Connecticut, where he was integral to various scientific developments and projects.
Educational Background in Chemistry and Biochemistry
Scott Bader has a strong academic background in organic chemistry and biochemistry. He obtained his B.S. in Biochemistry from The Ohio State University, where he studied from 1988 to 1999. He then pursued advanced studies at Boston College, earning his Ph.D. in Organic Chemistry from 2000 to 2005. Furthermore, he completed post-doctoral studies in Organic Chemistry at the University of Michigan from 2005 to 2008.